Cardiocomm Solutions Stock Analysis

EKGGF Stock  USD 0.01  0.00  0.00%   
CardioComm Solutions has over 413,810 in debt which may indicate that it relies heavily on debt financing. CardioComm Solutions' financial risk is the risk to CardioComm Solutions stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

CardioComm Solutions' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. CardioComm Solutions' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps CardioComm Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect CardioComm Solutions' stakeholders.
For many companies, including CardioComm Solutions, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for CardioComm Solutions, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, CardioComm Solutions' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that CardioComm Solutions' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which CardioComm Solutions is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of CardioComm Solutions to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, CardioComm Solutions is said to be less leveraged. If creditors hold a majority of CardioComm Solutions' assets, the Company is said to be highly leveraged.
CardioComm Solutions is overvalued with Real Value of 0.006699 and Hype Value of 0.01. The main objective of CardioComm Solutions pink sheet analysis is to determine its intrinsic value, which is an estimate of what CardioComm Solutions is worth, separate from its market price. There are two main types of CardioComm Solutions' stock analysis: fundamental analysis and technical analysis.
The CardioComm Solutions pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CardioComm Solutions' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in CardioComm Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

CardioComm Pink Sheet Analysis Notes

About 38.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. CardioComm Solutions had 1:5 split on the 26th of November 2007. CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange.The quote for CardioComm Solutions is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about CardioComm Solutions call MSc CHE at 416 977 9425 or check out https://www.cardiocommsolutions.com.

CardioComm Solutions Investment Alerts

CardioComm Solutions generated a negative expected return over the last 90 days
CardioComm Solutions has some characteristics of a very speculative penny stock
CardioComm Solutions has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
CardioComm Solutions has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity.
CardioComm Solutions has accumulated about 153.45 K in cash with (120.8 K) of positive cash flow from operations.
Roughly 38.0% of CardioComm Solutions shares are held by company insiders

CardioComm Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CardioComm Solutions's market, we take the total number of its shares issued and multiply it by CardioComm Solutions's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

CardioComm Profitablity

The company has Profit Margin (PM) of 0.28 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Technical Drivers

CardioComm Solutions technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CardioComm Solutions Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze CardioComm Solutions price data points by creating a series of averages of different subsets of CardioComm Solutions entire price series.

CardioComm Solutions Debt to Cash Allocation

Many companies such as CardioComm Solutions, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
CardioComm Solutions has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity.

CardioComm Solutions Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the CardioComm Solutions' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of CardioComm Solutions, which in turn will lower the firm's financial flexibility.

About CardioComm Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CardioComm Solutions prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CardioComm shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CardioComm Solutions. By using and applying CardioComm Pink Sheet analysis, traders can create a robust methodology for identifying CardioComm entry and exit points for their positions.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding CardioComm Solutions to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Complementary Tools for CardioComm Pink Sheet analysis

When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules